Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Mar 1;69(3):e131.
doi: 10.1097/MAT.0000000000001786. Epub 2022 Jul 7.

Anticoagulation on Extracorporeal Support: An Alternative Strategy

Alessandro Circelli  1 , Marta Velia Antonini  2 , Emiliano Gamberini  3 , Luca Bissoni  1 , Giovanni Scognamiglio  1 , Lorenzo Viola  1 , Vanni Agnoletti  1 ; ECMO Team of the Anesthesia and Intensive Care Unit, Bufalini Hospital—AUSL della Romagna
Affiliations
Comment

Anticoagulation on Extracorporeal Support: An Alternative Strategy

Alessandro Circelli et al. ASAIO J. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors have no conflicts of interest to report.

Comment on

References

    1. McMichael ABV, Ryerson LM, Ratano D, Fan E, Faraoni D, Annich GM. 2021 ELSO Adult and Pediatric Anticoagulation Guidelines. ASAIO J. 268:303-310, 2020.
    1. Gratz J, Pausch A, Schaden E, et al.: Low molecular weight heparin versus unfractioned heparin for anticoagulation during perioperative extracorporeal membrane oxygenation: A single center experience in 102 lung transplant patients. Artif Organs 44: 638–646, 2020.
    1. Piwowarczyk P, Borys M, Kutnik P, et al.: Unfractionated heparin versus subcutaneous nadroparin in adults supported with venovenous extracorporeal membrane oxygenation: A Retrospective, Multicenter Study. ASAIO J 67: 104–111, 2021.
    1. Krueger K, Schmutz A, Zieger B, Kalbhenn J: Venovenous extracorporeal membrane oxygenation with prophylactic subcutaneous anticoagulation only: An observational study in more than 60 patients. Artif Organs 41: 186–192, 2017.
    1. Frydman AM, Bara L, Le Roux Y, Woler M, Chauliac F, Samama MM: The antithrombotic activity and pharmacokinetics of enoxaparine, a low molecular weight heparin, in humans given single subcutaneous doses of 20 to 80 mg. J Clin Pharmacol 28: 609–618, 1988.

MeSH terms